Non-Squamous Non Small Cell Lung Cancer Recruiting Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0113720 (Non-Squamous Non Small Cell Lung Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03646968Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save StudyTreatment